• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人诱导多能干细胞衍生心肌细胞与人及食蟹猴心脏组织的比较基因表达谱分析。

Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue.

机构信息

Compound Safety Prediction, Pfizer, Inc., Groton, Connecticut 06340, USA.

出版信息

Toxicol Sci. 2013 Jan;131(1):292-301. doi: 10.1093/toxsci/kfs282. Epub 2012 Sep 14.

DOI:10.1093/toxsci/kfs282
PMID:22982684
Abstract

Cardiotoxicity is one of the leading causes of drug attrition. Current in vitro models insufficiently predict cardiotoxicity, and there is a need for alternative physiologically relevant models. Here we describe the gene expression profile of human-induced pluripotent stem cell-derived cardiocytes (iCC) postthaw over a period of 42 days in culture and compare this profile to human fetal and adult as well as adult cynomolgus nonhuman primate (NHP, Macaca fascicularis) heart tissue. Our results indicate that iCC express relevant cardiac markers such as ion channels (SCN5A, KCNJ2, CACNA1C, KCNQ1, and KCNH2), tissue-specific structural markers (MYH6, MYLPF, MYBPC3, DES, TNNT2, and TNNI3), and transcription factors (NKX2.5, GATA4, and GATA6) and lack the expression of stem cell markers (FOXD3, GBX2, NANOG, POU5F1, SOX2, and ZFP42). Furthermore, we performed a functional evaluation of contractility of the iCC and showed functional and pharmacological correlations with myocytes isolated from adult NHP hearts. These results suggest that stem cell-derived cardiocytes may represent a novel in vitro model to study human cardiac toxicity with potential ex vivo and in vivo translation.

摘要

心脏毒性是导致药物淘汰的主要原因之一。目前的体外模型不能充分预测心脏毒性,因此需要替代具有生理相关性的模型。在这里,我们描述了人诱导多能干细胞衍生的心肌细胞(iCC)在解冻后 42 天的基因表达谱,并将其与人类胎儿和成人以及成年食蟹猴(Macaca fascicularis)心脏组织进行了比较。我们的结果表明,iCC 表达了相关的心脏标志物,如离子通道(SCN5A、KCNJ2、CACNA1C、KCNQ1 和 KCNH2)、组织特异性结构标志物(MYH6、MYLPF、MYBPC3、DES、TNNT2 和 TNNI3)和转录因子(NKX2.5、GATA4 和 GATA6),并且缺乏干细胞标志物(FOXD3、GBX2、NANOG、POU5F1、SOX2 和 ZFP42)的表达。此外,我们还对 iCC 的收缩功能进行了功能评估,并显示出与成年食蟹猴心脏分离的心肌细胞之间的功能和药理学相关性。这些结果表明,干细胞衍生的心肌细胞可能代表一种新型的体外模型,可用于研究人类心脏毒性,并具有潜在的离体和体内转化。

相似文献

1
Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue.人诱导多能干细胞衍生心肌细胞与人及食蟹猴心脏组织的比较基因表达谱分析。
Toxicol Sci. 2013 Jan;131(1):292-301. doi: 10.1093/toxsci/kfs282. Epub 2012 Sep 14.
2
Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.人诱导多能干细胞衍生心肌细胞的鉴定:生物能量学及其在安全性筛选中的应用。
Toxicol Sci. 2012 Nov;130(1):117-31. doi: 10.1093/toxsci/kfs233. Epub 2012 Jul 27.
3
Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.多能干细胞衍生人心肌细胞的心脏毒性检测和最先进的生物分析:综述。
J Appl Toxicol. 2011 Apr;31(3):191-205. doi: 10.1002/jat.1663. Epub 2011 Feb 16.
4
Dental pulp of the third molar: a new source of pluripotent-like stem cells.第三磨牙牙髓:多能样干细胞的新来源。
J Cell Sci. 2012 Jul 15;125(Pt 14):3343-56. doi: 10.1242/jcs.096537. Epub 2012 Mar 30.
5
Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.利用人诱导多能干细胞衍生的心肌细胞评估药物诱导的致心律失常风险。
Toxicol Sci. 2011 Sep;123(1):281-9. doi: 10.1093/toxsci/kfr158. Epub 2011 Jun 20.
6
Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue.全球转录谱分析揭示了人类干细胞来源的心肌细胞簇与心脏组织之间的相似性和差异。
Physiol Genomics. 2012 Feb 27;44(4):245-58. doi: 10.1152/physiolgenomics.00118.2011. Epub 2011 Dec 13.
7
Cardiomyocytes derived from human pluripotent stem cells for drug screening.人多能干细胞来源的心肌细胞用于药物筛选。
Pharmacol Ther. 2012 May;134(2):180-8. doi: 10.1016/j.pharmthera.2012.01.005. Epub 2012 Jan 16.
8
Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells.与多能干细胞来源的心肌细胞相比的人类胎儿心脏转录组。
Development. 2015 Sep 15;142(18):3231-8. doi: 10.1242/dev.123810. Epub 2015 Jul 24.
9
The application of human embryonic stem cell technologies to drug discovery.人类胚胎干细胞技术在药物研发中的应用。
Drug Discov Today. 2007 Sep;12(17-18):688-99. doi: 10.1016/j.drudis.2007.07.005. Epub 2007 Aug 30.
10
Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.简明综述:基于人类多能干细胞的心脏和肝脏毒性评估模型。
Stem Cells. 2011 May;29(5):744-8. doi: 10.1002/stem.631.

引用本文的文献

1
Transcriptional atlas analysis from multiple tissues reveals the expression specificity patterns in beef cattle.多组织转录图谱分析揭示肉牛的表达特异性模式。
BMC Biol. 2022 Mar 29;20(1):79. doi: 10.1186/s12915-022-01269-4.
2
Ryanodine Receptor Type 2: A Molecular Target for Dichlorodiphenyltrichloroethane- and Dichlorodiphenyldichloroethylene-Mediated Cardiotoxicity.肌质网钙释放通道蛋白 2:滴滴涕和滴滴伊介导心脏毒性的分子靶点。
Toxicol Sci. 2020 Nov 1;178(1):159-172. doi: 10.1093/toxsci/kfaa139.
3
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties.
人多能干细胞衍生心肌细胞的冷冻保存对其分子和功能特性并无损害。
Stem Cell Res. 2020 Mar;43:101698. doi: 10.1016/j.scr.2019.101698. Epub 2020 Jan 7.
4
Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry.这些是心肌细胞吗?方案开发揭示了样品制备对流式细胞术鉴定心肌细胞准确性的影响。
Stem Cell Reports. 2019 Feb 12;12(2):395-410. doi: 10.1016/j.stemcr.2018.12.016. Epub 2019 Jan 24.
5
Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates.在温度可控的384孔板中,使用钙敏荧光染料测量人诱导多能干细胞衍生的心肌细胞合胞体的收缩情况。
J Vis Exp. 2018 Oct 18(140):58290. doi: 10.3791/58290.
6
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.人诱导多能干细胞(hiPSC)衍生细胞评估药物心脏毒性:机遇与问题。
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:83-103. doi: 10.1146/annurev-pharmtox-010617-053110. Epub 2017 Oct 6.
7
Enhanced Human-Induced Pluripotent Stem Cell Derived Cardiomyocyte Maturation Using a Dual Microgradient Substrate.使用双微梯度基质增强人诱导多能干细胞衍生心肌细胞的成熟
ACS Biomater Sci Eng. 2016 Dec 12;2(12):2231-2239. doi: 10.1021/acsbiomaterials.6b00426. Epub 2016 Oct 17.
8
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?验证化疗诱导心脏毒性的药物基因组学:缺失了什么?
Pharmacol Ther. 2016 Dec;168:113-125. doi: 10.1016/j.pharmthera.2016.09.009. Epub 2016 Sep 5.
9
Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production.心房利钠肽产生的新型微小RNA调节因子
Mol Cell Biol. 2016 Jun 29;36(14):1977-87. doi: 10.1128/MCB.01114-15. Print 2016 Jul 15.
10
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.人诱导多能干细胞衍生的心肌细胞为遗传性心血管疾病建模带来新机遇。
Cardiol Res Pract. 2016;2016:3582380. doi: 10.1155/2016/3582380. Epub 2016 Mar 27.